Professor, Department of Chemical & Biomolecular Engineering
Professor, Department of Bioengineering
Philomathia Chair in Alternative Energy
Faculty Senior Scientist, Lawrence Berkeley National Laboratory
CEO, Joint BioEnergy Institute
Jay Keasling is a pioneer in engineering microbes and metabolism. During the early 2000s, Jay led a UC Berkeley research team to use engineered yeast to synthetically produce artemisinin, the powerful anti-malarial drug. Researchers at the Keasling Lab are now using the same technology to produce other pharmaceuticals, commodity chemicals, and cellulosic biofuels.